DE60036676D1 - G-protein-gekoppelter rezeptor-ähnliche proteine - Google Patents

G-protein-gekoppelter rezeptor-ähnliche proteine

Info

Publication number
DE60036676D1
DE60036676D1 DE60036676T DE60036676T DE60036676D1 DE 60036676 D1 DE60036676 D1 DE 60036676D1 DE 60036676 T DE60036676 T DE 60036676T DE 60036676 T DE60036676 T DE 60036676T DE 60036676 D1 DE60036676 D1 DE 60036676D1
Authority
DE
Germany
Prior art keywords
protein
coupled receptor
polypeptide
similar proteins
homologues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60036676T
Other languages
English (en)
Other versions
DE60036676T2 (de
Inventor
Beate Peter
Mark Anthony O'reilly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9925641.4A external-priority patent/GB9925641D0/en
Priority claimed from GB0009973A external-priority patent/GB0009973D0/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE60036676D1 publication Critical patent/DE60036676D1/de
Application granted granted Critical
Publication of DE60036676T2 publication Critical patent/DE60036676T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60036676T 1999-10-29 2000-10-24 G-protein-gekoppelte rezeptor-ähnliche proteine Expired - Fee Related DE60036676T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9925641.4A GB9925641D0 (en) 1999-10-29 1999-10-29 Novel polypeptide
GB9925641 1999-10-29
GB0009973 2000-04-20
GB0009973A GB0009973D0 (en) 2000-04-20 2000-04-20 Novel polypeptide

Publications (2)

Publication Number Publication Date
DE60036676D1 true DE60036676D1 (de) 2007-11-22
DE60036676T2 DE60036676T2 (de) 2008-02-07

Family

ID=26244160

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60036676T Expired - Fee Related DE60036676T2 (de) 1999-10-29 2000-10-24 G-protein-gekoppelte rezeptor-ähnliche proteine

Country Status (7)

Country Link
US (1) US20030149242A1 (de)
EP (1) EP1096009B1 (de)
JP (1) JP2001211889A (de)
AT (1) ATE375390T1 (de)
DE (1) DE60036676T2 (de)
ES (1) ES2291177T3 (de)
GB (1) GB2356864B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001033221A1 (en) * 1999-11-02 2001-05-10 Smithkline Beecham Corporation Axor35, a g-protein coupled receptor
WO2002000719A2 (en) * 2000-06-23 2002-01-03 Tularik Inc. Human and mouse g-protein couipled receptors
IL161695A0 (en) * 2001-11-09 2004-09-27 Pfizer Prod Inc Functional assay for agonist activation of receptors
BR112013009532A2 (pt) * 2010-10-20 2016-07-19 Danisco Us Inc celulase de tricoderma termoestável

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885824A (en) * 1990-12-24 1999-03-23 The Regents Of The University Of Michigan Recombinant genomic clone encoding the histamine H2 receptor, methods for production thereof, and protein produced therefrom
US5865824A (en) * 1997-04-21 1999-02-02 Chen; Fung-Jou Self-texturing absorbent structures and absorbent articles made therefrom
US6093545A (en) * 1997-12-04 2000-07-25 Millennium Pharmaceuticals, Inc. Methods for detecting nucleic acid molecules encoding a member of the muscarinic family of receptors
JP4214442B2 (ja) * 1997-12-26 2009-01-28 萬有製薬株式会社 新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタータンパク質
NZ510712A (en) * 1998-10-13 2004-11-26 Arena Pharm Inc Non-endogenous, constitutively activated human G protein-coupled receptors
JP2003534767A (ja) * 1998-11-20 2003-11-25 アリーナ・フアーマシユーチカルズ・インコーポレーテツド ヒトオーファンｇタンパク質共役型受容体
JP2000189171A (ja) * 1998-12-25 2000-07-11 Banyu Pharmaceut Co Ltd 新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタ―タンパク質
US6204017B1 (en) 1999-10-07 2001-03-20 Schering Corporation Polynucleotide encoding a histamine receptor

Also Published As

Publication number Publication date
GB2356864B (en) 2004-10-20
ES2291177T3 (es) 2008-03-01
GB2356864A8 (en) 2001-10-10
EP1096009B1 (de) 2007-10-10
DE60036676T2 (de) 2008-02-07
US20030149242A1 (en) 2003-08-07
EP1096009A1 (de) 2001-05-02
GB0026251D0 (en) 2000-12-13
ATE375390T1 (de) 2007-10-15
JP2001211889A (ja) 2001-08-07
GB2356864A (en) 2001-06-06

Similar Documents

Publication Publication Date Title
AUPP051497A0 (en) Antimicrobial peptides
AU2001290837A1 (en) Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation
WO1998004702A3 (en) Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use
EP1092727A3 (de) G-protein rezeptor
WO2002061076A1 (en) Adiponectin-associated protein
WO2002072616A3 (en) Transfection complexes
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
WO2002101052A3 (en) Salutaridinol 7-o-acetyltransferase and derivatives thereof
EP1006126A3 (de) Peptide mit osteogener Aktivität
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
AU2865801A (en) Therapeutic peptides
WO2002038607A3 (en) A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
DK1425295T3 (da) Modificerede peptider og deres anvendelse til behandling af autoimmune sygdomme
NO20011263L (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
EP1096008A3 (de) Menschlicher G-Protein-gekoppelter Rezeptor, PFI-014
GB0008504D0 (en) Novel polypeptide
EP1094109A3 (de) Menschlicher G-Protein-gekoppelter Rezeptor, PFI-010
EP1225183A3 (de) Humaner G-Protein gekoppelter Rezeptor
DE60021707D1 (de) Beta-primeverosidase gen
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
ATE201233T1 (de) Tgf-beta rii rezeptor nukleinsäuresequenz, dadurch kodiertes peptid, und verwendungen davon
WO2002092624A3 (en) G-protein coupled receptor
WO2003033536A3 (en) G-protein coupled receptor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee